138 related articles for article (PubMed ID: 14644446)
1. Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin.
Zhou JY; Wang ZF; Ren XM; Tang MZ; Shi YL
FEBS Lett; 2003 Dec; 555(2):375-9. PubMed ID: 14644446
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
4. Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex.
Otto H; Hanson PI; Chapman ER; Blasi J; Jahn R
Biochem Biophys Res Commun; 1995 Jul; 212(3):945-52. PubMed ID: 7626135
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
6. Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane.
Li MF; Shi YL
Acta Pharmacol Sin; 2006 Jan; 27(1):66-70. PubMed ID: 16364212
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
Whelchel DD; Brehmer TM; Brooks PM; Darragh N; Coffield JA
Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
[TBL] [Abstract][Full Text] [Related]
8. Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation.
Macaulay SL; Hewish DR; Gough KH; Stoichevska V; MacPherson SF; Jagadish M; Ward CW
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):217-24. PubMed ID: 9164859
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol.
Cai S; Sarkar HK; Singh BR
Biochemistry; 1999 May; 38(21):6903-10. PubMed ID: 10346912
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
Chen F; Foran P; Shone CC; Foster KA; Melling J; Dolly JO
Biochemistry; 1997 May; 36(19):5719-28. PubMed ID: 9153412
[TBL] [Abstract][Full Text] [Related]
12. Distinct exocytotic responses of intact and permeabilised chromaffin cells after cleavage of the 25-kDa synaptosomal-associated protein (SNAP-25) or synaptobrevin by botulinum toxin A or B.
Lawrence GW; Foran P; Dolly JO
Eur J Biochem; 1996 Mar; 236(3):877-86. PubMed ID: 8665909
[TBL] [Abstract][Full Text] [Related]
13. The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool.
Stigliani S; Raiteri L; Fassio A; Bonanno G
J Neurochem; 2003 Apr; 85(2):409-21. PubMed ID: 12675917
[TBL] [Abstract][Full Text] [Related]
14. Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers.
Höhne-Zell B; Gratzl M
FEBS Lett; 1996 Sep; 394(2):109-16. PubMed ID: 8843145
[TBL] [Abstract][Full Text] [Related]
15. Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses.
Schiavo G; Stenbeck G; Rothman JE; Söllner TH
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):997-1001. PubMed ID: 9023371
[TBL] [Abstract][Full Text] [Related]
16. Characterization of SNARE protein expression in beta cell lines and pancreatic islets.
Wheeler MB; Sheu L; Ghai M; Bouquillon A; Grondin G; Weller U; Beaudoin AR; Bennett MK; Trimble WS; Gaisano HY
Endocrinology; 1996 Apr; 137(4):1340-8. PubMed ID: 8625909
[TBL] [Abstract][Full Text] [Related]
17. [Biological effects of toosendanin, an active ingredient of herbal vermifuge in Chinese traditional medicine].
Shi YL; Wang WP
Sheng Li Xue Bao; 2006 Oct; 58(5):397-406. PubMed ID: 17041722
[TBL] [Abstract][Full Text] [Related]
18. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine.
Shi YL; Li MF
Prog Neurobiol; 2007 May; 82(1):1-10. PubMed ID: 17363132
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation of the 25-kDa synaptosomal protein (SNAP-25) in vitro occurs in the absence of an enzyme, but is stimulated by binding to syntaxin.
Veit M
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):145-51. PubMed ID: 10600650
[TBL] [Abstract][Full Text] [Related]
20. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.
Sakaba T; Stein A; Jahn R; Neher E
Science; 2005 Jul; 309(5733):491-4. PubMed ID: 16020741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
